Crossmark

The therapeutic efficacy of mesenchymal stromal cells on experimental colitis was improved by the IFN-γ and poly(I:C) priming through promoting the expression of indoleamine 2,3-dioxygenase

Crossref DOI link: https://doi.org/10.1186/s13287-020-02087-7

Published Online: 2021-01-07

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lim, Ji-Young

Kim, Byung-Su https://orcid.org/0000-0002-7210-316X
Ryu, Da-Bin

Kim, Tae Woo

Park, Gyeongsin

Min, Chang-Ki
Funding

Funding for this research was provided by:

National Research Foundation of Korea (2016R1A6A3A11933697)
License Information

Text and Data Mining valid from 2021-01-07

Version of Record valid from 2021-01-07
More Information

Article History

Received: 19 June 2020

Accepted: 7 December 2020

First Online: 7 January 2021

Ethics approval and consent to participate

: All animal experiments have been approved by the Institutional Animal Care and Use Committees of the Catholic University of Korea (Seoul, Republic of Korea), and are in compliance with the Laboratory Animal Act from the Korean Ministry of Food and Drug Safety (No. 15278).

: Not applicable

: The authors declare they have no competing financial and non-financial interests.

Document is current

Any future updates will be listed below